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Abstract 
 
HoLaMa is a Klenow sub-fragment lacking the 3’-5’ exonuclease domain, whose gene 
codes for residues 515-928 of Escherichia coli DNA polymerase I. The enzyme was 
designed in a previous study starting from different Klenow enzymes, with the aim of 
studying a mini-DNA polymerase with NMR spectroscopy. 
In the present work, we studied a new purification protocol for the production of 
HoLaMa in order to obtain an appropriate quantity for NMR analysis. We tested three 
different purification procedure and at the end, we collected 5.8 mg of HoLaMa 
(Volume 1.8 mL, concentration 67 μM). 
After the purification, we started the study of HoLaMa by NMR spectroscopy, focusing 
on the nature of enzyme-substrate interactions and studying the kinetics of the reaction. 
Our preliminary studies were designed to understand the characteristic NMR signals of 
HoLaMa under different conditions of temperature and buffer; finally, we also focused 
our analysis on the interactions between protein, DNA and nucleotides. 
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1. INTRODUCTION 
 
DNA polymerases are enzymes universally responsible for replication and repair of 
DNA. These enzymes vary in sequence and structure depending on their cellular 
function. 
In Escherichia coli there are 5 different DNA polymerases, i.e. I, II, III, IV and V. 
DNA polymerase II possesses both 5’→3’ polymerase and 3’ → 5’ exonuclease  
(proofreading) activities. It features good fidelity of replication and very low 
processivity.1,a 
DNA polymerase III is the largest polymerase, composed by 10 different subunits, it is 
expressed in a low number of copies in E. coli (about 20) but sustains a very high 
reaction rate.2,1 
DNA polymerase IV and V are enzymes involved in DNA repair mechanisms in 
bacteria, and they are expressed during the SOS response.3 
DNA polymerase I is the most abundant in E. coli (about 400 copy/cell), and was the 
first discovered DNA polymerase (by A. Kornberg in 19564). 
DNA pol I is composed of 928 amino acids, accounting for a molecular mass equal to 
103 kDa5,6. 
E. coli DNA pol I is competent in 3 distinct functions: 
5’→3’ exonuclease activity, provided by amino acids 1-323 
3’→5’ exonuclease activity, provided by amino acids 324-517 
5’→3’ polymerase activity, provided by residues 521-928. 
Its tertiary structure looks like an open right hand, with the 3’-5’ exonuclease domain 
protruding from the palm.4 
Proteolytic treatment splits DNA pol I into two fragments, i.e. containing the 1-232 a.a. 
and 324-928 a.a., respectively; the largest fragment is called Klenow enzyme 
(containing the  3’→5’ exonuclease and 5’→3’ DNA polymerase domains), and is 
characterized by a molecular mass equal to 68 kDa. The exonuclease activity is 
necessary to remove incorrect nucleotides at the end of the DNA chain by hydrolysis of 
the phosphodiester bond between the 3′-hydroxyl (-OH) and the 5' phosphate group. 
                                                          
a   An important characteristic of DNA polymerases is the processivity, defined as the average 
number of nucleotides added by the enzyme after binding to and before dissociating from the 
DNA substrate. 
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FIG 1: Structure of DNA polymerase I of Thermus aquaticus (Taq): the structural elements of 
fingers, thumb and palm are shown; fingers and thumb recognize and lock the DNA in the right 
position near the active site, for the extension reaction, inside the palm. 
 
1.1 Mechanism of polymerase reaction 
 
The mechanism of DNA polymerase action occurs in four steps, accompanied by 
conformational changes of the enzyme: binding of the DNA, of a deoxynucleoside 
triphosphate (dNTP), phosphodiester bond formation, and pyrophosphate release. 
In the first step, the binding of the double‐stranded primer/template substrate to the 
enzyme is followed by a conformational change of the thumb domain to wrap the DNA. 
Important interactions occur at the end of the primer, in order to position it in proximity 
of the active site (palm domain).7 
In the second step, the dNTP binds to the binary enzyme-DNA complex and during this 
step the enzyme is able to discriminate between correct versus incorrect nucleotides. 
The negative charge of the dNTP interacts with positively charged amino acids, i.e. 
Arg754, Lys758, Arg682 and with the two Mg2+ ions coordinated with Asp705 and 
Asp882; 
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A further conformational 
change from the open to the 
closed state is achieved by the 
rotation of the O-helix, located 
in the fingers domain. In this 
closed ternary complex, an 
active state is reached with all 
components in place for the 
catalysis of the phosphodiester 
bond formation. 
In the third step, two divalent 
metal ions are involved (Mg2+ 
A and B, respectively), both of 
them are coordinated by the 
oxygen of the triphosphate of an incoming dNTP and the carboxyl oxygen of a residue 
in the active site, thus stabilising the structure and charging of the expected 
pentacovalent transition state. 8,7 
 
Ion A activates the terminal 3’-OH group of the primer to facilitate the nucleophilic  
attack to the α‐phosphate of the dNTP.  
 
The fourth step is the release of pyrophosphate, which is assisted by the metal ion B and 
involves another conformational change, from a close to an open state. 
During the opening of the fingers domain, DNA-Pol I translocates to ensure the 
processivity of the reaction. 
The scheme of the reaction catalysed by DNA polymerases is: 
 
dNTP + DNAn  PPi + DNAn+1 
 
dNTP - deoxynucleotide triphosphates 
PPi - inorganic pyrophosphate 
 
 
 
FIG 2: Schematic structure of the DNA polymerase I 
active site. 
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1.2 HoLaMa 
 
HoLaMa is a Klenow sub-fragment lacking the 3’-5’ exonuclease domain, whose gene 
codes for residues 515-928 of Escherichia coli DNA polymerase I. The enzyme was 
designed in a previous study by Alejandro Hochkoeppler, Fabio Lapenta and Cristina 
Elisa Martina, thanks to protein engineering and analysis of different tertiary structures 
of the Klenow enzyme stored in the “RCSB Protein Data bank”: 2KZZ [BRAUTIGAM 
CA 1999]9, 1D8Y [TEPLOVA M 1999]10, 1KFD [BEESE LS 1993], 1DPI [OLLIS DL 
1985]. 
The first modification planned was to eliminate the 3’-5’ exonuclease domain (from 
amino acid M324 to H519), but this deletion was thought to produce a Klenow sub-
fragment featuring very low solubility, probably due to the exposure to the solvent of 
the α-helix G521-N543 (normally interacting with the exonuclease domain) which does 
contain some hydrophobic amino acids.  
Some specific mutations were therefore inserted with the aim to confer to HoLaMa 
satisfactory solubility in water: 
 
P522E            L523K                F526E               M531R                V534E               P535R 
 
To verify the stability of HoLaMa upon the introduction of these site-specific mutations, 
the energy scoring functions of DeepView and Foldit were used. 
Few other specific site-specific mutations were then introduced to optimize the protein: 
K520M              L561K               L646D                  L744C             C907S 
 
The mutation of lysine with methionine (K520M) was introduced to provide the start 
codon to the gene coding for HoLaMa. 
The two leucines (L561 and L646) were partially exposed to the solvent, while the new 
substitutions with lysine and aspartic acid should increase the enzyme solubility (L561K 
and L646D). 
L744C and C907S mutations were designed to obtain a protein useful for FRET studies, 
hence a new cysteine inside the fingers domain was introduced and the only natural 
cysteine present was substituted (C907S). 
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The final primary structure of HoLaMa is here reported: 
 
METGERNVEE NIERPLERVL SRIERNGVKI DPKVLHNHSE ELTKRLAELE 
KKAHEIAGEE FNLSSTKQLQ TILFEKQGIK PLKKTPGGAP STSEEVLEEL 
ALDYPLPKVI LEYRGLAKLK STYTDKLPDM INPKTGRVHT SYHQAVTATG 
RLSSTDPNLQ NIPVRNEEGR RIRQAFIAPE DYVIVSADYS QIELRIMAHL 
SRDKGLLTAF AEGKDIHRAT AAEVFGCPLE TVTSEQRRSA KAINFGLIYG 
MSAFGLARQL NIPRKEAQKY MDLYFERYPG VLEYMERTRA QAKEQGYVET 
LDGRRLYLPD IKSSNGARRA AAERAAINAP MQGTAADIIK RAMIAVDAWL 
QAEQPRVRMI MQVHDELVFE VHKDDVDAVA KQIHQLMENS TRLDVPLLVE 
VGSGENWDQAH.5 
 
 
FIG 3: 3D view of the Klenow fragment and HoLaMa with site-specific mutation   
 
Two different variants of HoLaMa were designed, bearing or not a hexahistidine tag at 
the N-terminal of the protein; in a previous work, only HoLaMaHis-tagged was 
produced and tested in kinetic assays. 
 
 
 
Site-specific mutation 
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1.3 Production of recombinant proteins 
 
With the term “recombinant protein”, it is denoted a manipulated form of a protein 
whose gene is carried by a recombinant DNA (usually an expression vector) and whose 
production takes place inside an organism called host. 
Many steps are needed for obtaining a recombinant protein: i) the cloning of the gene 
into an appropriate expression vector; ii) the insertion of the construct inside the most 
suitable host (by transformation); iii) the induction of the protein overexpression and iv) 
the purification of the target protein and its characterization. 
The synthetic gene coding for the truncated form of the Klenow Fragment, i.e. 
HoLaMa, was cloned into the expression vector pBADHisB (see below) and the host 
chosen for protein expression was Escherichia coli TOP10.  
 
1.3.1 Host strain 
 
Escherichia coli is a Gram-negative, facultative anaerobic, rod-shaped bacterium of the 
genus Escherichia that is commonly found in the lower intestine of humans and 
animals. It is the most widely studied prokaryotic model, and represents an important 
microorganism in biotechnology and microbiology, where it is commonly used as a host 
for the over-expression of recombinant proteins. 
The bacterium can be easily grown with inexpensive media in a laboratory setting, 
using a wide variety of carbon sources. Under favourable conditions, E. coli features 
fast growth rate and it takes only 20 minutes to reproduce. 
In this work, we used Luria-Bertani (LB) medium supplemented with ampicillin (100 
µg/mL).  
 
1.3.2 pBAD expression vector 
 
The optimized gene coding for HoLaMa was cloned into the pBADHisB expression 
vector (Invitrogen), using NcoI and PstI restriction enzymes, yielding pBAD-HoLaMa 
construct devoid of the hexahistidine-tag sequence. 
A vector is a plasmid, that means a small, circular, double-stranded DNA molecule 
which is autonomously replicated from the chromosomal DNA. 
Site-specific mutation 
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In nature, cells can contain a variable 
amount and type of plasmids, carrying 
genes that may be useful to the 
microorganism under particular conditions, 
and they may guarantee its survival, e.g. 
supplying antibiotic resistance.  
Artificial plasmids serve as important tools 
in genetics and biotechnology, where they 
are commonly used to clone and over-
express target genes. Expression plasmids 
used to this aim contain specific features: a 
gene conferring resistance to specific 
antibiotics (ampicillin is frequently used 
for bacterial strains), an origin of 
replication to allow the bacterial cells to 
replicate the plasmid DNA, and suitable restriction sites for the cloning. Many plasmids 
are commercially available for a wide range of uses. 
For the production of HoLaMa, the pBADHisB vector was chosen, which contains an 
arabinose-inducible promoter (araBAD) able to control the protein expression. In 
particular, the ara promoter is part of the arabinose operon, found in many bacteria and 
containing araB, araA and araD genes responsible for the production of enzymes, 
needed for the catabolism of arabinose as carbon source and the arabinose transporters 
(araE and araFGH). Using this vector, the induction of protein expression is possible 
by adding L-arabinose to the growth medium. In our experiments, we used 1 mM 
arabinose as inducer of HoLaMa production. 
The araBAD promoter is positively and negatively regulated by the regulatory AraC 
protein, whose gene is also present in the plasmid (figure 4). 
  
 
 
 
 
 
FIG 4: Map of the pBAD expression vector  
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1.4 Nucleic acids 
 
In nature, there are two different nucleic acids: DNA (DeoxyriboNucleic Acid) and 
RNA (RiboNucleic Acid). They are bio-macromolecules formed by two antiparallel 
strands (DNA) or by a single strand (RNA). Each strand consists of deoxyribose/ribose 
units linked by a phosphodiester bond, this link connecting each 3'-hydroxyl-group of 
the carbohydrate moiety to the next 5'-phosphate-group. Therefore, a single filament has 
two different ends, a free 3'-OH called 3'-end, and a free 5'-phosphate group, called the 
5'-end. DNA can be synthesized only in the 5’- 3’ direction. 
Each pentose unite is linked at the C1’, via N-glycosidic bond, with a nitrogenous base 
(nucleobase), i.e.: 
– purines: adenine and guanine;  
– pyrimidines: cytosine and thymine (only for DNA), cytosine and uracil (only for 
RNA). 
The two strands of DNA are annealed to 
each other via hydrogen bonding between 
the nucleobases (C ≡ G, A = T). 
The function of DNA is to transfer the 
genetic information from one generation to 
the next, thanks to transcription and 
translation steps. 
 
 
 
 
FIG 5: Schematic view of the two strands of DNA. 
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1.5 NMR 
 
A NMR (Nuclear Magnetic Resonance) spectrum is a plot of the intensity of emission 
(or absorption) against chemical shift (δ). Although the absolute resonance frequency 
depends on the applied magnetic field, the chemical shift is independent of the field 
strength; therefore, the positions of the peaks do not change with the magnetic field. On 
the other hand, the resolution of the spectrum will increase with the applied magnetic 
field. The equation: 
 
 
 
Describes the chemical shift, where νsample is the resonance frequency of the sample and 
νref is the resonance frequency of a standard reference compound present in the sample 
(both frequencies ν, measured in the same magnetic field B0). 
 
The molecules are placed in a magnetic field, after a relaxation delay (tr), where the spin 
of the atoms aligns along the field in parallel or anti-parallel way, radio frequency 
pulses (60-1000MHz) are applied, the active nuclei respond and they emit a free 
induction decay (FID) which is then recorded in acquisition time (tacq). 
The spectrum is obtained thanks to the Fourier transformation that converts the FID into 
a frequency domain. 
 
NMR analysis can be used to give information about the distances between atoms in a 
protein, and to predict the tertiary structure; it is also possible to study the fold/unfold 
conformation of proteins and their dynamics in solution11.   
Most structure determinations used the proton NMR spectrum, but for larger proteins it 
is necessary to interpreted also 13C spectrum and 15N spectrum (1H, 13C, 15N are NMR 
active nuclei with magnetic moment: nuclear spin IV, I=1/2V); to do this, it is 
essential to growth the recombinant microorganism, producing the target protein, in a 
proper medium enriched with these isotopes.12 
The first experiments in the nuclear magnetic resonance spectroscopy of proteins, were 
one-dimensional NMR, where it is possible to observe only one kind of nuclear species 
at a time. However, these type of spectra are very difficult to interpret because of the 
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overlapping signals of many hydrogens inside the proteins; to improve the technique, an 
important development was the introduction of two dimensional NMR.13 
In the figure 6 we can see the dispersion of different groups, usually present in a protein 
in a typical 1D-HNMR. The specific peaks around 10 ppm correspond to the H of 
indole group of tryptophan. The peak around 4.7 ppm stems from the water (D2O) 
presents in the sample: when protein spectrum is collected with D2O most signals of 
proteins (backbone amide proton, side chain amide, amino proton, hydroxyl and 
carboxyl protons) disappear.  
                                 
 
FIG 6: 1D H-NMR spectrum of HoLaMa in Tris Buffer with 5% v/v D2O (standard), at 600 
MHz. T=293K, pH 8,  
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FIG 7: Four different amino acid, Alanine (A), Tryptophan (W), Lysine (K) and Phenylalanine 
(L) which show the different groups who we can find  in the NMR spectrum. 
 
Signal dispersion of NMR spectra is an indicator for whether a protein is natively folded 
or partially unfolded. In unfolded/folded proteins, the signal for backbone amide and for 
methyl group changes the chemical shift position, for example the backbone amide in 
unfolded proteins is present only between 8-8.5 ppm while in folded proteins it will be 
found in general in the range between 8.5-12 ppm ( depends on the relative abundance 
of α-helix, β-strand, random coil) 
 
The characteristic signal for DNA in the 1H-NMR spectrum are reported: 
1-1.5 ppm, methyl group of thymine  
1.5-3 ppm, 2’ protons present on the deoxyribose 
3.5-5 ppm, all other ring protons present in 1’, 3’, 4’ and 5’ position of the ring 
5.5-8.5 ppm, aromatic protons of the bases 
7-8.5 ppm, amino protons 
11 ppm, imino protons in DNA hairpin loop structure 
12-14 ppm, imino protons in DNA duplex structure 
15-16 ppm, imino protons in DNA triplex structure 
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FIG10 8 :Proton spectrum of double-stranded DNA (24 nucleotides) in 90:10 – H2O:D2O 
 
In protein-DNA complexes, most of the DNA signals overlap with protein signals; 
however, the imino DNA protons are distinguishable and are located in the region 
around 11-16 ppm. 
 
In two-dimensional NMR, peaks have two frequency coordinates, representing any 
combination of chemical shift (and/or other property for diffusion of molecules in the 
solution). All 2D experiments have the same basic format sequence of actions: 
a) Preparation 
b) Evolution 
c) Mixing 
d) Detection 
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FIG 9: Scheme for 2D experiment (P-preparation, E-evolution, M-mixing, D-detection) 
 
During the preparation and the mixing periods it can be performed a pulse depending on 
the nature of the experiment. The detection period is the same as for the 1D experiment, 
during which the instrument collects the FID. 
The evolution period provides the key for the generation of the second dimension: the 
initial 90°x pulse places the equilibrium magnetization in the x-y plane along the +y 
axis, after which it will evolve according to this chemical shift offset. After a time 
period, t1, the vector is moved through an angle of 360°νt1 and is then subjected to the 
second 90°x pulse. This second pulse places the y-component along the z-axis while the 
x-component remains in that plan and produces the detective FID. This experiment is 
repeated a number of times with the t1 interval increased by a uniform amount each 
time, and the resulting FID stored separately.14 
 
 
NOE: Nuclear Over-hauser effect, this technique allows to detect the spatial proximity 
among nuclei in a molecule 
NOESY: Homonuclear 2D NOE spectrum 
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The NOE may be defined as the change in intensity of one resonance when the spin 
transitions of another resonance are somehow perturbed from their equilibrium 
populations. The perturbation of interest usually corresponds to either a saturation of a 
resonance signal, that is equalized to the spin population (α and β) difference across the 
corresponding transitions or, alternatively, to a selected pulse applied at 180 ° which 
inverts the spin populations. 
 
After change population levels, the system will relax back to the equilibrium population 
state, altering the population level of other spin. 
The enhancement of NOE is expressed as a relative intensity change between the 
equilibrium intensity I0 and that in the presence of the NOE I: 
 
 
 
 indicates the NOE observed for spin I when spin S is perturbed. 
The intensity and sign of the NOESY effect depend on the tumbling rate of the 
molecule in solution: small molecules have positive NOESY (i.e.: the signal intensity 
increases) while large molecules (biological molecules) have negative NOESY (the 
signals intensity decreases).14 
 
In a NOESY spectrum the cross peaks are generated by cross relaxation, thus indicating 
that there are cross relaxations between close spins.  
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The NOESY pulse sequence is shown in the figure the first part of the sequence is 
composed by 90°-t1-90° sequence, following initial excitation and t1 evolution, the 
magnetization vector exists in the transverse plane. The second 90° pulse places one 
component of this vector onto the –z-axis and therefore generates the required 
population inversion that enable transition NOEs to develop during the sequence mixing 
period. After tm, the new population is sampled with a 90° pulse and the FID collected. 
(the component that remain in the transverse plane are those detected in the COSY -
correlation spectroscopy- experiment)15 
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2. AIM OF THE WORK 
 
The aim of this work was to study the artificial enzyme HoLaMa, a sub-fragment of the 
Klenow DNA polymerase of Escherichia coli. The project was divided into two parts 
carried out at the Department of Industrial Chemistry of the University of Bologna, and 
at the Department of Chemistry of the Konstanz University (Germany). 
During the first part of the experimental work we tried to define a new efficient protocol 
for the production of HoLaMa in order to obtain an appropriate quantity for NMR 
analysis. In a previous study, the synthetic gene coding for HoLaMa was cloned and its 
expression in E. coli was optimized. Starting from these data, we tried to define a proper 
purification protocol since the previous one, including a precipitation step with 
ammonium sulphate, led to a degradation of HoLaMa into two fragments (likely due to 
a contaminant protease). 
The aim of the second part was the study of HoLaMa by NMR spectroscopy, focusing 
on the nature of enzyme-substrate interactions and studying the kinetics of the reaction. 
Our preliminary studies were designed to understand the characteristic NMR signals of 
HoLaMa under different conditions of temperature and buffer; finally, we also focused 
our analysis on the interactions between protein, DNA and nucleotides. 
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3. MATERIALS AND METHODS 
 
3.1 Bacterial strain 
 
Escherichia coli TOP10 (Invitrogen) 
Genotype: F- mcrA ∆(mrr-hsd RMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 araD139 
∆(araA-leu)7697 galU galK rpsL endA1 nupG. 
 
3.2 Medium 
 
Luria-Bertani (LB) medium contains tryptone, the enzymatic digestion (by trypsin) 
product of casein, yeast extract, rich in vitamins and other nutrients, and sodium 
chloride. The concentration of the different components is: 10, 5, and 10 g/L of 
tryptone, yeast extract, and sodium chloride, respectively. 
 
3.3 Buffers 
 
Buffer A: 50 mM TrisHCl, 50 mM NaCl, 1 mM EDTA, pH 8 
Buffer B: 50 mM TrisHCl, 2 M NaCl, 1 mM EDTA, pH 8 
Buffer C: 50 mM TrisHCl, 150 mM NaCl, 1 mM EDTA, pH 8 
Lysis buffer: 50 mM TrisHCl, 50 mM NaCl, pH 8 
Desalting buffer: 50 mM TrisHCl, 1mM EDTA, pH 8 
NMR buffer: 20 mM Na2HPO4, 300 mM NaCl 
 
3.4 Expression protocol 
 
To prepare the pre-inoculum, a single colony of E. coli TOP10/pBAD-HoLaMa from a 
Petri dish was grown in 5 mL of LB (containing ampicillin 100 g/mL) at 37 °C 
overnight under shaking (180 rpm). This bacterial culture was diluted (1:500) in a flask 
containing 250 mL of LB medium with ampicillin, and incubated for 9 h at 30°C. 
The induction was performed by adding arabinose (1 mM), then cultures were incubated 
overnight at 30 °C. Cells were harvested by centrifugation at 5000 g at 4 °C for 20 
minutes and cells pellets were frozen at – 20 °C. 
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We produced a total amount of 9 L of induced cultures with a biomass yield of about 4-
4,3 g/L. 
 
3.5 Evaluation of bacterial growth  
 
Determining the optical density of a growing culture is a common method to quantify 
various important culture parameters, e.g. cell concentration or biomass production. The 
continuous detection of the culture optical density is the most general and powerful tool 
for pursuing optimal yields and controlling reproducibility in many fermentation 
strategies. 
Photometers quantify the optical density of liquid samples by comparing the intensity of 
light that has passed through and the intensity of the incident light.  
In spectroscopy, the absorbance A is usually defined as:  
 
 
 
I - Intensity of transmitted light 
I0 - Intensity of incident light 
The optical density depends on path length of the sample. 
 
OD - optical density  
A - Absorbance 
L - Thickness of sample 
 
Generally, the wavelength of choice for estimating bacterial growth is 600 nm. 
The OD600nm evaluation of the pre-inoculum culture gives information about cell 
concentration and therefore, knowing the initial OD value, one can determine the 
appropriate dilution of the pre-inoculum to the flask culture.  
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3.6 Extraction of proteins 
 
Cell pellets (from 2 L of culture) were resuspended in 60 mL of buffer A (Tris-HCl 50 
mM, NaCl 50 mM, EDTA 1mM pH 8) with 1mM PMSF (phenylmethylsulfonyl 
fluoride) as seryl-proteases inhibitor. After resuspension, cells were homogenized on ice 
with a glass potter, then subjected to 5 sonication cycles at 18 W using a Misonix 
Sonicator (total time 2 minutes, steps of 15 sec pulse and 15 sec pause).  
The sample was centrifuged at 12,000 g for 30 minutes at 4 °C to recover soluble 
proteins and then filtered. 
 
3.7Ultrafiltration  
 
Ultrafiltration is the process of separating small particles and dissolved molecules from 
solution based on size exclusion and is frequently used for the separation of proteins 
from buffer components:  buffer exchange, desalting or concentration. 
For the concentration of HoLaMa, we used an Amicon Stirred Cell (Millipore) equipped 
with a semipermeable cellulose membrane with a molecular weight cut-off of 30 kDa 
(HoLaMa, featuring a molecular weight of 47. kDa, is retained by the ultrafilter). 
The cell system is continuously filled with nitrogen gas under low pressure to force the 
solution through the membrane, while retaining the macromolecules; the magnetic 
stirring favours the solution concentration, avoiding proteins precipitation. 
For the buffer exchange before NMR analysis, we used Vivaspin centrifugal 
concentrators (volume of 5 ml, Sartorius), with a semipermeable membrane with porous 
dimension (MWCO) of 10 kDa. The centrifugal force is able to pull particles and solids 
away from the membrane to the bottom of the tube, while proteins are collected in an 
impermeable pocket and then recovered. 
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3.8 Purification steps 
 
Three different procedures were tested and compared. The first purification protocol 
was attempted with the product of 500 ml of induced E. coli TOP10/pBAD-HoLaMa 
cultures. The sequence of the chromatographic steps was:  
 Affinity chromatography with a Cibacron Blue column 
 Affinity chromatography with a HiTrap Heparin column 
 Size-exclusion with a Superdex 200 column  
 Anion exchange with a HiTrap Q HP column 
 
The second protocol was performed using 4 L of induced cultures and the sequence of 
the chromatographic steps was:  
 Affinity chromatography with a Cibacron Blue column 
 Affinity chromatography with a HiTrap Heparin column 
 Size-exclusion with a Superdex 200 column  
 Affinity chromatography with a HiTrap Blue HP 
 
For the third procedure we used the pellet of 2 L of induced cultures with the following 
sequence of chromatographic steps: 
 Affinity chromatography with a Cibacron Blue column 
 Affinity chromatography with a HiTrap Heparin column 
 Affinity chromatography with a HiTrap Blue HP 
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3.9 Affinity chromatography: Cibacron blue resin  
 
Blue Sepharose is a group specific adsorbent with affinity for a wide variety of 
enzymes. The dye ligand, Cibacron Blue F3G-A, is covalently attached to the matrix 
(agarose) via the triazine part of the dye molecule. Several proteins interact rather 
specifically with the dye, due to its structural similarity with nucleotide cofactors. 
The prepacked column HiTrap Blue HP 
(5 ml, GE Healthcare Life Science) was 
washed with 5-10 column volumes (CV) 
of water and 5-10 CV (25-50 mL) of 
buffer A (Tris-HCl 50 mM, NaCl 50 
mM, EDTA 1 mM pH 8). The sample 
was then loaded onto the column with a 
slow flow (0,5-0,4 mL/min) to maximize 
the binding on the ligand. The elution 
was done with an increasing salt 
gradient: 0-50 % buffer B (50 mM 
TrisHCl, 2M NaCl, 1 mM EDTA) in a 
volume of 50 mL, applying a flow of 1 
mL/min. 
The Cibacron Blue 3G column (25 mL resin) was washed with 10 CV with water and 
then with 10 CV with buffer A (Tris-HCl 50 mM, NaCl 50 mM, EDTA 1 mM pH 8) 
before loading the sample (flow 0.5 mL/min). The elution was performed with a linear 
gradient 50 mM -1 M NaCl, using buffer B (50 mM TrisHCl, 2M NaCl, 1mM EDTA) 
at a flow of 2 mL/min. 
 
3.10 Affinity chromatography: HiTrap Heparin HP  
 
The prepacked HiTrap Heparin column (5 mL, GE Healthcare Life Science) contains 
Sepharose (brand name derived from Separation-Pharmacia-Agarose) as matrix and it 
is useful for the purification of proteins with affinity for DNA, since heparin mimics a 
polynucleotide. 
Heparin has two main modes of interaction with proteins. It can operate as an affinity 
ligand, and also functions as a high capacity cation exchanger, due to its anionic 
   FIG 10 : Dye Ligand Cibacron Blue 
- 22 - 
 
sulphate groups. Heparin is a member of the glycosaminoglycan family of 
carbohydrates and consists of a variably sulphated repeating disaccharide units, as 
shown here: 
 
 
FIG 11: Heparin structure 
 
Before the chromatography, the ionic strength of the sample was reduced by 
ultrafiltration, to obtain a protein solution with a concentration of NaCl equal to 50 mM. 
The column was washed with water (5-10 CV), and equilibrated with 10 CV of buffer A 
(Tris-HCl 50 mM, NaCl 50 mM, EDTA 1 mM pH 8). 
The sample was loaded onto the column (flow 0,5 mL/min), then a wash step with 10 
CV of buffer A was performed. 
Proteins were eluted with an increasing salt concentration gradient (50-600 mM) using 
buffer B (50 mM Tris-HCl, 2M NaCl, 1 mM EDTA) in a volume of 50 mL, using a 
flow of 1 mL/min. 
 
3.11 Size exclusion chromatography: Superdex-200 
 
Size-exclusion chromatography, also known as Gel Filtration (GF), is a 
chromatographic method by which molecules in solution are separated by their size or 
molecular mass, passing through cross-linked agarose, dextran or acrylic matrices.  
It is usually applied to macromolecules (proteins and polymers). The mixture of 
molecules moves through a porous resin: smaller molecules diffuse into the pores and 
therefore move through the bed slowly, while large molecules are excluded from the 
pores thus eluting quickly. Gel Filtration Chromatography may be used for the analysis 
of molecular mass, for the separation of components in a mixture, or for salt removal 
and buffer exchange, depending on the range of fractionation chosen. 
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The Superdex 200 column (volume equal to 125 mL), previously calibrated, was 
washed with water then equilibrated with buffer C (50 mM Tris-HCl, 150 mM NaCl, 1 
mM EDTA, pH 8). The sample, concentrated using the Amicon Stirred Ultrafiltration 
cell, was loaded using a calibrated loop (2 mL), and the elution was done with the same 
buffer C at 0,6 mL/min flow rate. 
 
3.12 Anion exchange chromatography: HiTrap Q HP 
 
Ion exchange chromatography can be used to separate proteins depending on their 
ability to interact, in different ways, with a specific charged resin. In particular, the 
stationary phase for the anion exchange chromatography is commonly made of porous 
cross linked agarose charged with a quaternary amine (Q, strong exchanger) or 
diethylaminoethyl (DEAE, weak exchanger), to generate the positive charge. Proteins 
that contain negative charges (glutamate, aspartate groups) are bound to the resin. 
In general, proteins are eluted by increasing the ionic strength (salt concentration) of the 
buffer or, occasionally, by changing the pH. In the first case, the salt ions (typically Na+ 
or Cl-) compete with the bound proteins for the charges on the surface of the medium, 
thus inducing the elution of the bound proteins. Proteins with the lowest net charge at 
the selected concentration/pH will be the first ones eluted from the column; proteins 
with the highest charge will be retained longer on the matrix and will be eluted last. The 
higher net charge of the protein is, the higher ionic strength is required for its elution. 
The charge density of the matrix is maintained using a suitable pH of the buffers used.  
The isoelectric point is the pH at which a protein has no a net charge. Since HoLaMa 
possesses an isoelectric point equal to 6, the anion exchange chromatography can be 
performed using buffers at a higher pH (usually between 7 and 10).  The column 
chosen, HiTrap Q HP (5 mL, GE Healthcare Life Science) containing a sepharose-based 
resin (strong anion exchanger), was equilibrated with buffer A (50 mM Tris-HCl, 50 
mM NaCl, 1 mM EDTA, pH 8). The elution was performed with a linear gradient 50 -
600 mM NaCl, in 50 mL volume, with a flow of 1 ml/min. 
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3.13 Determination of protein concentration 
 
The concentration of proteins in solution can be determined using the method of 
Bradford (1976). This procedure requires the addition of the Coomassie Blue G-250 dye 
to a protein solution. The Absorbance at 595 nm of the samples is then determined with 
a spectrophotometer. The data are compared to a calibration curve previously obtained 
with solution of BSA at known concentration (bovine serum albumin, 1 mg/mL stock 
solution).  
Standard samples were prepared using 4.9 mL of dye solution and different volumes of 
BSA, to obtain a final concentration of protein equal to 0.1, 0.2, or 0.3 mg/mL. 
The unknown samples were prepared by adding a suitable volume of protein to 4,9 mL 
of dye. Each determination was performed in duplicate. 
 
3.14 SDS-PAGE 
 
Denaturing gel electrophoresis can provide information about the molecular mass and 
the relative purity of proteins; the most common use of this technique is the qualitative 
analysis of complex mixtures of proteins. 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) is a useful 
technique to analyse protein fractions eluted from chromatographic columns. 
SDS-PAGE requires that proteins are denatured: to do this, samples are boiled for 5 
minutes in the presence of the anionic detergent sodium dodecyl sulfate (SDS) and of 
the reducing agent mercaptoethanol (BME). By this means, after the treatment, each 
protein will be devoid of disulphide bridges and will have a uniform negative charge. 
Accordingly, the electrophoretic mobility will depend mainly on size. Polyacrylamide 
gels (12,5 % concentration) were used for the separation of mixtures of proteins. 
- 25 - 
 
 
 
FIG 12: Scheme of the reaction for the synthesis of the polyacrylamide gel  
 
An electric field, applied across the gels by a power supply, drives each negative protein 
to migrate across the gels toward the anode. The mobility depends on the size of the 
proteins, so small molecules will move faster through the pores than large proteins.  
Following electrophoresis, gels can be stained with a Coomassie Brilliant Blue R-250 
solution (0,25 % Coomassie Blue, 30% ethanol, 10% acetic acid), for 2 h under shaking. 
The Coomassie Blue dye binds to proteins through ionic interaction between dye 
sulfonic acid group and positive protein amine group. After staining, gels are placed in a 
destaining solution (10% acetic acid and 30% ethanol) until protein bands appear. 
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 3.15 NMR 
 
All experiments were performed at 293 K on a Bruker Avance III 600 MHz 
spectrometer equipped with a TCI-H/C/N triple resonance cryoprobe. 
Protein samples were prepared in a final volume of 510 µL containing 5 % Vol. of D2O 
as field lock. 
1D spectra were acquired with 64-128 accumulated scans, solvent suppression was 
achieved by the Watergate sequence. Acquired data was processed and analysed using 
TopSpin 3.2 software16. 
An important step before the acquisition of data is the water suppression: water signal is 
a major source of inaccuracy in the determination of biomolecules’ peaks. 
In fact, some peaks may be hidden under the water peak or, even if the peaks are 
sufficiently intense to be identified, they may overlay with the tail of the water peak, 
which acts as a baseline distortion and makes the determination of the peak less 
accurate.17 
Several physical or chemical phenomena make the water signal suppression difficult: 
the radiation damping (RD) effects, the impact of various instabilities on the position of 
the water signal and the ‘‘faraway water’’ effect. RD is an intrinsic physical 
phenomenon in all NMR experiments; if the solvent suppression is not efficient enough, 
RD may affect the residual signal and generate a great hump, which will affect the 
quantification of metabolite signals close to the solvent peak. 
The description of the phenomenon is explaining in review by Krishnan and Murali 
(2013)18: The precessing transverse magnetization of the water protons after a radio 
frequency pulse induces an electromagnetic field (emf) in the receiver coil. This creates 
an oscillating current that generates a transverse magnetic field at the same frequency. 
This induced field rotates the magnetization of the solvent spins to its equilibrium 
toward the direction of the applied magnetic field, before other relaxation mechanisms 
can take effect. The rate, at which the solvent magnetization is rotated to equilibrium, is 
given by a characteristic time constant known as the radiation damping time (srd). For 
example, a sample of water in an NMR spectrometer operating at 400 MHz will have a 
srd value of around 20 ms. In contrast, the expected spin lattice (T1) and spin–spin 
relaxation (T2) times of water have durations on the order of more than hundreds of 
milliseconds. 
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The decay of the time domain signal is dominated by the much shorter srd, rather than 
the longer T2. Several powerful solutions based on either hardware (probe engineering) 
modifications or pulse field gradient have developed effective suppression of RD in 
biomolecular NMR applications. 
Variations in the position of the water resonance frequency come from various origins: 
in particular, from variations of pH, salt concentration and temperature in different 
sample. These variations, even small, can be sufficient to shift the water signal by a few 
hertz, thus decreasing the efficiency of the suppression scheme. 
“Faraway” water effect is due to the nuclei located at the edge of the sensitive NMR 
volume, which are subjected to a reduced RF field and different B0 as in the other part 
of the sample, this contributing to make the water peak broader. 19 
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4. RESULTS AND DISCUSSION 
 
4.1 HoLaMa overexpression  
 
In order to obtain a high amount of purified 
HoLaMa for NMR analysis, we cultured 
six batches (1.5 L each) of E. coli cells 
subjected to the overexpression of the 
target protein. From 9 L of induced E. coli 
TOP10/pBAD-HoLaMa cultures we 
obtained about 4 g/batch of biomass that 
were mixed together and then divided into 
aliquots to be used for the subsequent 
purification steps. 
SDS-PAGE analysis demonstrated the 
effectiveness of the induction procedure. As 
shown in figure 13, aliquots of total proteins 
extracted from the biomass of four different 
overexpression batches were compared. The difference between not induced and 
induced samples is sharp, with the band corresponding to HoLaMa only detected in the 
protein extracts obtained from induced cultures.  
 
4.2 First purification procedure 
 
The first procedure used for the purification of HoLaMa included 4 different 
chromatographic steps: a) affinity with HiTrap Blue HP, b) affinity with HiTrap 
Heparin HP, c) gel filtration chromatography and d) anion exchange with HiTrap Q. 
The soluble protein extract, obtained from 500 mL of induced cells, was loaded onto a 5 
mL HiTrap Blue affinity column. The corresponding chromatogram (see figure n…) 
shows that a huge amount of protein did not bind to the column, but it was eluted with 
the flow through. During the elution, performed with a linear NaCl gradient (0.05-1 M), 
other contaminant proteins were separated from HoLaMa. The elution was performed in 
50 mL and fractions of 1 mL were collected. Aliquots of the protein samples eluted 
from the HiTrap Blue column were analysed by SDS-PAGE (figure 14B).  
FIG 13: SDS-PAGE of total protein extracts from 
four different overexpression batches. (M: protein 
molecular weight markers; NI: Not Induced; I: 
Induced) 
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FIG 14: A: Chromatogram of the purification step performed with the HiTrap Blue affinity 
column. (FT1,2,3: Flow Through    W1,2: Wash). B: SDS-PAGE of representative fractions 
eluted from the HiTrap Blue affinity column (M: protein molecular weight markers; Pre: the 
protein extract loaded onto the column).  
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As shown in figure 14, HoLaMa was present in fractions 14- 29 (second peak of the 
chromatogram, corresponding to 630-910 mM NaCl) in very high concentration; on the 
contrary, HoLaMa was not detected at significant levels in the flow through and in the 
washing fractions. Using the Bradford assay, we determined the initial amount of total 
proteins before the HiTrap Blue chromatography: 65 mg in a 25 mL volume, 
corresponding to a concentration of 2.61 mg/mL. 
After the first purification step, all fractions containing HoLaMa were pooled and the 
protein concentration was equal to 0.51 mg/mL, corresponding to 10.7 mg in 21 mL. 
This pool of fractions was concentrated and desalted with an ultrafiltration Amicon cell 
(equipped with a YM30 membrane), then loaded onto a second affinity column, i.e. a 
HiTrap Heparin. The elution was performed increasing the NaCl concentration from 50 
to 600 mM, and fractions of 0.9 mL were collected. Figure 15 shows the chromatogram 
and the corresponding SDS-PAGE. 
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FIG 15: A: Chromatogram of the HiTrap Heparin affinity column. (FT2,3: Flow Through; W1: 
Wash) ..B: SDS-PAGE of fractions eluted from the HiTrap Heparin affinity column (M: protein 
molecular weight markers; Pre: sample loaded onto the column).  
 
The chromatogram shows a very small flow through peak, indicating that most proteins 
could bind to the resin, and three elution peaks. As revealed by the SDS.PAGE analysis, 
HoLaMa was present only in the third peak (fractions 10-15 with a NaCl concentration 
ranging from 770 to 815 mM), while in the first two peaks (fractions 1-9) the protein 
was absent. 
The fractions from 10 to 15 (about 5.5 mL) were concentrated to 2.2 mL with an 
Amicon ultrafiltration cell (YM30), then loaded onto a gel filtration column (Superdex-
200), using a 2 mL loop. 
This purification step was useful to eliminate a contaminant protein around 110 kDa 
(lane 5 in the gel, figure 16B). 
 
B 
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FIG 16: A: elution profile of the Gel Filtration chromatography. B: SDS-PAGE of fractions 
eluted from the Superdex 200 column (M: protein molecular weight markers; Pre: Sample 
loaded onto the column).  
 
To improve the purity of the recovered protein, fractions from 44 to 53 (Vtot = 7.5 mL) 
were collected and loaded onto an ion exchange column (HiTrap Q HP). The protein 
concentration of the sample before this chromatography was 0.178 mg/mL, 
corresponding to 1.34 mg of total protein. Unfortunately, this purification step failed 
because HoLaMa was unable to bind the anionic resin and the protein did elute with the 
flow through and the washing fractions (see Figure 17). 
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FIG 17: SDS-PAGE of relevant fractions eluted from the HiTrap Q column. (M: protein 
molecular weight marker; Pre: Sample loaded onto the column). 
 
4.3 Second purification  
 
For the second purification procedure we used the biomass obtained from 4 L of E. coli 
TOP10/pBAD-HoLaMa induced cultures; after a sonication step in 65 mL of buffer A, 
the lysate was centrifuged and filtered. 
The purification started with a Cibacron Blue affinity chromatograpy. The concentration 
of protein loaded onto the column was 15.8 mg/mL, corresponding to approximately 1 g 
of total proteins.  
Figure 18 shows the elution profile of HoLaMa from the Cibacron Blue column and the 
SDS-PAGE of some eluted fractions. 
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FIG 18: A: Cibacron Blue chromatogram (FT 1,2,3: Flow Through; W1: Wash). B: SDS-PAGE of 
fractions obtained from the Cibacron Blue column (M: protein molecular weight marker; Pre: 
sample loaded onto the column).  
 
As clearly visible in the SDS-PAGE gel, the amount of recovered HoLaMa was very 
high, but a consistent fraction of the protein did not bind to the column, and was eluted 
with the flow through (lane FT2, FT3) and the washing steps (lane W1). In particular, the 
protein concentration of the second flow-through was determined as equal to 3.15 
mg/mL, corresponding to about 80 mg in 25 mL (FT2). Considering a similar amount of 
protein inside the FT3 and W1 samples, we estimate that we lost approximately 1/3 of 
total proteins. 
The elution was performed with a linear NaCl gradient (0.05 - 1 M): HoLaMa was 
detected in fractions 15-48, featuring a NaCl concentration ranging from 0.72 to 1 M. 
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Fractions containing HoLaMa were pooled and subjected to an ultrafiltration step 
(Amicon cell equipped with a YM30 membrane) to decrease NaCl concentration to 50 
mM. After this step, the protein content was reduced to 40 mg in a volume of 20 mL.  
The subsequent purification step was performed using a HiTrap Heparin affinity column 
(see figure 19) and the elution was carried out with a linear NaCl gradient from 50 to 
600 mM. 
 
 
 
FIG 19: A: HiTrap Heparin chromatogram (FT 1,2: Flow Through; W1: Wash). B: SDS-PAGE of 
fractions obtained from the HiTrap Heparin column (M: protein molecular weight marker; Pre: 
sample loaded onto the column).  
 
The elution profile shows two different peaks; HoLaMa was present in the second peak, 
in fractions from 9-16 (about 8 mL). This pool was concentrated to 2.1 mL (final 
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concentration of proteins 4.71 mg/mL, corresponding to 9.8 mg) and then loaded onto a 
gel filtration column (Superdex 200, 1.6 x 70 cm).  
 
 
 
FIG 20: A: Gel filtration chromatogram. B: SDS-PAGE of fractions obtained from the Gel 
Filtration column (M: protein molecular weight marker; Pre: sample loaded onto the column).  
 
Unfortunately, the purification step using the Superdex 200 column was not very 
efficient: the low molecular weight contaminants were not adequately separated from 
HoLaMa. However, the target protein eluted at a volume corresponding to the expected 
molecular mass of the enzyme monomeric form.  
We collected fractions from 40 to 51 (the volume was about 10 mL, and the NaCl 
concentration was 150 mM); then, this pool was diluted to decrease the NaCl 
concentration with a diluent buffer  (50 mM Tris HCl, 1 mM EDTA). The protein 
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concentration of the sample, determined according to the Bradford assay, was 0.51 
mg/mL, corresponding to about 9.6 mg of total protein. Therefore, the amount of 
protein loaded and collected from the gel filtration column was the same. 
The sample was loaded onto the last column, a Hi Trap Blue HP affinity column, using 
a flow equal to 0.4 mL/min, and the elution was carried out with a linear NaCl gradient 
(from 0.05 to 1 M).  
 
 
 
FIG 21: A: HiTrap Blue affinity chromatogram. (FT1,2,3: Flow Through    W1,2: Wash). B: 
SDS-PAGE of fractions eluted from the HiTrap Blue affinity column (M: protein molecular 
weight marker; Pre: sample loaded onto the column).  
 
According to the SDS-PAGE analysis, fractions from 5 to 23 (final volume 18 mL, 
NaCl concentration about 700 mM) were colected; this pool was then diluted and 
concentrated using a Amicon ultrafiltration cell (YM30 membrane), to reduce NaCl 
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concentration to about 50 mM. The final volume of the sample was 4.6 mL with a 
protein concentration of 0.39 mg/mL, corresponding to 1.8 mg of purified HoLaMa. 
 
The amount of protein recovered after each step of the purification cycle is reported in 
Table 1. 
 
Second purification 
 
 Conc (mg/mL) Vsample (mL) Total protein (mg) 
Pre Cibacron Blue 15.8 65 1027 
Pre HiTrap Heparin 1.90 21 39.9 
Pre Gel Filtration 4.71 2.1 9.80 
Pre HiTrap Blue 0.51 19 9.60 
HoLaMa purified 0.39 4.6 1.80 
 
Table 1: recovery of proteins after each purification step . 
 
In order to compare the purification level obtained with this procedure, aliquots of the 
protein sample were analysed by SDS-PAGE: 
 
 
 
FIG 22: SDS- PAGE of protein samples obtained during the second purification. 
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4.4 Third purification 
 
To increase the yield of the first purification step, we decided to independently extract 
proteins from two aliquots of biomass (each corresponding to 2 L of culture), and to 
repeat twice the Cibacron Blue affinity column. 
The chromatograms of these two parallel Cibacron Blue affinity steps were very similar, 
as well as the amount of total proteins obtained in the extractions (about 450 mg each).  
 
 
 
FIG 23: A: Cibacron Blue chromatogram (FT 1,2: Flow Through; W1: Wash). B: SDS-PAGE of 
fractions obtained from the Cibacron Blue column (M: protein molecular weight marker; Pre: 
sample loaded onto the column).  
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HoLaMa was mainly eluted in fractions 9-39, featuring a total volume of about 60 mL 
and a protein concentration equal to 2.4 mg/mL. This protein solution was diluted in a 
buffer devoid of NaCl, then concentrated to 25 mL using an Amicon ultrafiltration cell. 
Unfortunately, during this step, a consistent amount of proteins was lost, as revealed by 
the Bradford assay. The initial amount of proteins was indeed equal to 144 mg, while 
the concentration after the ultrafiltration step was 3.17 mg/mL, corresponding to about 
80 mg of proteins in 25 mL. 
After centrifugation, the protein sample was loaded onto a HiTrap Heparin column and 
the elution was performed with a 50-600 mM NaCl gradient. Fractions 10-16 (V= 6.7 
mL), containing a high amount of HoLaMa (as shown in Figure 23), were pooled, 
diluted and concentrated to reduce the NaCl concentration using an Amicon 
ultrafiltration cell. 
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FIG 23: A: HiTrap Heparin chromatogram (FT 1,2: Flow Through; W1: Wash). B: SDS-PAGE of 
fractions obtained from the HiTrap Heparin column (M: protein molecular weight marker; Pre: 
sample loaded onto the column).  
 
The amount of protein obtained after this step was about 16.8 mg in 25 mL 
(concentration 0.67 mg/mL). 
This sample was finally loaded onto the last column, a HiTrap Blue, and the elution was 
performed with a linear 0.05– 1M NaCl gradient. The result is reported in figure 24. 
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FIG 24: A: Chromatogram of HiTrap Blue affinity. B: SDS-PAGE of fractions obtained from 
the HiTrap Blue affinity column (M: protein molecular weight marker; Pre: sample loaded onto 
the column).  
 
As revealed by the SDS-PAGE analysis, fractions 11 to 25 contained purified HoLaMa. 
These fractions, featuring a NaCl concentration from 670 to 930 mM, were pooled and 
diluted to decrease the NaCl concentration to 300 mM. The amount of HoLaMa was 
assayed by the Bradford method, resulting equal to 4.8 mg. 
 
 
 
 
 
 
 
 
 
 
Table 2: Purification summary table. 
 
The final protein solution was mixed with the purified sample obtained from the second 
purification procedure (1.8 mg of HoLaMa in 4.6 mL). The solution was finally 
concentrated to obtain 1.9 mL of sample with a concentration of 3.1 mg/mL, i.e. 66 µM 
(total protein 5.8 mg).  
 
 
 
Third purification 
 
 Conc (mg/mL) V sample (mL) Total protein (mg) 
Pre Cibacron Blue I° 6.23 65 405 
Pre Cibacron Blue II° 7.98 65 518 
Pre ultrafiltration 2.40 60 144 
Pre HiTrap Heparin 3.17 25 79.3 
Pre HiTrap Blue 0.67 25 16.8 
Post HiTrap Blue 0.33 15 4.95 
HoLaMa purified 0.96 5.0 4.80 
B 
- 43 - 
 
4.5 NMR 
 
A preliminary NMR study was performed to obtain and interpret the signals of 
HoLaMa, which is a protein featuring a quite large molecular mass (46 kDa). Data were 
acquired using a Bruker Avance III 600 MHz spectrometer and spectra were processed 
using TopSpin 3.2 (baseline corrections were manually applied). First experiments were 
performed with 66 µM HoLaMa in 50 mM Tris-HCl buffer, 300 mM NaCl, 1 mM 
EDTA, the same buffer used for the purification of the enzyme, and 5 % D2O 
(standard). Spectra were acquired at 293K or 288K, overnight. 
Under these conditions, the concentration of Tris-HCl was about 1000 times higher 
when compared to the protein concentration; therefore, the principal signals detected 
were derived from Tris protons; however, in region of the spectrum relative to the 
aliphatic and the aromatic signals dispersed peaks corresponding to HoLaMa were 
detected. 
             
    
FIG 25: Detail of Aliphatic part of H1-NMR spectrum of HoLaMa  
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FIG 26: Detail of Aromatic and Backbone NH part of H1-NMR spectrum of HoLaMa  
 
The different temperature conditions tested revealed a better resolution of the spectrum 
under the higher temperature; indeed, at the lower temperature the viscosity of the 
sample usually increases, implying that the molecules move slowly and the peaks are 
wider. For this reason, subsequent experiments were carried out at 293K. 
We also collected a NOESY spectrum of HoLaMa under the same conditions used for  
1H-NMR: again, the Tris buffer did predominate the spectrum, but we were able to 
detect the aromatic and aliphatic diagonal signals. 
 
FIG 27 : 2D-NOESY H1-NMR spectrum of HoLaMa  
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In subsequent experiments we exchanged the 50 mM Tris buffer with 20 mM 
phosphate, using a small aliquot of the protein sample to test the stability of HoLaMa in 
the new environment. Phosphate is a non-protonated buffer suitable for NMR 
experiments. 
The concentration of HoLaMa for this test was about 15 µM, the protein sample was 
mixed with 30 µL of D2O, and the spectrum has been recorded overnight. 
We compared the two 1D 1H-NMR collected using Tris or phosphate buffer to dissolve 
HoLaMa. In the figure below (28) in Blue is shown the spectrum for HoLaMa in 
phosphate buffer, while in Red is reported the spectrum for HoLaMa in Tris buffer. The 
peaks of the protein are clearly overlapping, confirming that HoLaMa was natively 
folding, while the Tris peaks disappear. However, some impurities around 3.5 ppm are 
present. 
 
 
FIG 28: H1-NMR spectrum of HoLaMa: in Blue the spectrum in phosphate buffer and in Red 
the spectrum in Tris buffer 
 
We prepared a new phosphate buffer to repeat the NMR experiment, without HoLaMa, 
in order to check the presence of these impurities. 
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FIG 29: H1-NMR spectrum of Phosphate buffer. 
 
The spectrum indicates the absence of any impurities, since only the peak of water was 
detected (at 4,7 ppm). 
 
We focused further work on the study of the polymerase reaction between a short DNA 
template (16 mer) and HoLaMa.  
                      3’ CGCGCGCGAAAAAAAA 5’ 
5’ GCGCGCGCTTTTTTT 3’ 
The synthetic DNA used in all NMR experiments was provided by GenScript (USA). 
First of all, we studied the NMR signal of the single nucleotide dTTP and of the 
complex DNA-dTTP in solution. Further, HoLaMa was added to the DNA-dTTP 
solution to follow the reaction steps. 
 
The spectrum for dTTP was recorded a 293 K for 10 minutes. The volume of the sample 
was 510 µL, containing 31 µL of the 1 mM dTTP stock solution (final concentration 61 
µM), 449 µL of distilled water and 30 µL of D2O. 
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FIG 30: H1-NMR spectrum of dTTP 
 
The NMR signals visible on the spectrum are: 
1.741 ppm methyl for the thymine group 
2.209 ppm for proton (2 and 2’) of deoxyribose 
4.044 ppm for proton 3’- 4’- 5 and 5’ of deoxyribose 
4.718 ppm for water 
6.179 ppm for proton 1’ of deoxyribose 
7.602 ppm for proton of thymine (position 5) 
 
Specific signals for imino protons are not present, because dTTP is a free nucleotide and 
we can see the peak for imino proton only in a double stranded DNA (when imino 
proton is engaged in a hydrogen bond), anyway the imino protons are present after 10.2 
ppm. 
Afterwards, we analysed the short double stranded DNA; the sample was prepared with 
71 µL of the DNA stock solution 360 µM (final concentration 50 µM), 378 µL of 
distilled water and 30 µL of D2O. The spectrum was collected overnight at 293 K.  
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FIG 31: Detail of  H1-NMR spectrum of DNA, from 12 to 15 ppm. 
 
After a manual base line correction, it was possible to integrate the peaks in the imino 
protons range; the integral value is about 15, corresponding to 15 imino protons, which 
formed hydrogen bonds between nitrogen bases. 
I1 = 1 
I2 = 14 
Total I = 15 expected number of hydrogen bonds formed 
Once acquired the H1-NMR spectrum of dTTP and DNA separately, we decided to 
prepare a mixing solution 1:1 of DNA and dTTP. To do this, we added to the DNA 
sample previously analysed 26 µL of the dTTP solution (1 mM), to a final concentration 
of 48 µM. 
The sample was analysed overnight at 293 K. The NMR spectrum obtained does not 
significantly differ from the spectrum obtained with DNA only. 
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FIG 32: Detail of  H1-NMR spectrum of DNA in BLU and DNA+dTTP in RED, from 12 to 14.5 ppm. 
 
We then prepared a sample containing HoLaMa, DNA and dTTP with a concentration 
ratio of 1:1:1. The mixture contained:  
403 µL HoLaMa  final concentration 39.5 µM 
56 µL DNA  final concentration 39.5 µM 
41 µL dTTP  final concentration 40 µM 
30 µL D2O 
 
The spectrum was collected overnight at 293 K, and it was compared with the two 
spectra previously acquired. In the presence of HoLaMa, the peaks show a shift toward 
low field and they present a different shape. In particular, the peak around 12.7 ppm is 
broader and does not have a definite minimum, while peaks around 13.6 and 14.2 ppm 
are broader and smaller. These differences can be caused by the interactions between 
HoLaMa and the DNA during the catalytic events. 
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FIG 33: Detail of H1-NMR spectrum of DNA in BLU, DNA+dTTP in RED and 
DNA+dTTP+HoLaMa in GREEN from 12 to 14.5 ppm. 
 
To attempt a better understanding of the spectra, we decided to prepare another sample 
containing only HoLaMa and DNA: if the signals of this were similar to the signal of 
the DNA only or the DNA + dTTP spectrum, we could confirm the catalytic action of 
HoLaMa, as seen in figure 33 in green. 
The sample was prepared with a very low concentration of both components 
(unfortunately we had only a small residual amount of HoLaMa). The spectrum was 
collected at 293 K for about 3 days. The mixture contained (in final volume of 500 µL): 
95 µL HoLaMa  final concentration 9.5 µM 
14 µL DNA  final concentration 10 µM 
30 µL D2O 
361 µL MQ 
As expected, the resultant spectrum presents a very high noise in the imino part and the 
peaks are not distinguishable. 
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FIG 34: Detail of  H1-NMR spectrum of DNA+HoLaMa in BLU, DNA+dTTP+HoLaMa in 
RED from 12 to 14.5 ppm. 
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5. CONCLUSION 
 
In the present work, we studied the artificial enzyme HoLaMa, a sub-fragment of the 
Klenow DNA polymerase of Escherichia coli, lacking the proofreading domain.  
During the first part of the experimental work, we tested three different purification 
procedures in order to obtain an amount of purified HoLaMa appropriate for NMR 
analysis. The best purification procedure consisted of the following steps: 
1) first step with Cibacron blue affinity chromatography; 
2) ultrafiltration of pooled fractions for desalting and concentration; 
3) second step with a HiTrap Heparin affinity column; 
4) ultrafiltration of pooled fractions for desalting and concentration; 
5) third step with a HiTrap Blue affinity column. 
The most troublesome step turned out to be the ultrafiltration after the Cibacron blue 
chromatography, since about 50 % of the total protein was lost during this 
desalting/concentration procedure. Despite this loss, we could finally obtain about 6 mg 
of purified HoLaMa in 1.8 mL (final concentration 67 μM). 
Future work will be devoted to optimize this critical step, e.g. performing a dialysis step 
instead of the ultrafiltration carried out with an Amicon membrane to desalt and 
concentrate the protein sample. 
 
The second experimental part consisted in the study of HoLaMa by NMR spectroscopy, 
in particular towards the nature of enzyme-substrate interactions and the kinetics of the 
reaction. Unfortunately, the total amount of purified HoLaMa (about 6 mg) allowed us 
to perform only a preliminary study. In particular, we could assess: 
- the folding/unfolding state of the protein 
- the stability of HoLaMa in different buffers (Tris or Phosphate) 
- the interactions with DNA and dTTP. 
Starting from these observations, it would be very interesting to pursue further this 
analysis, using a higher amount of purified HoLaMa. 
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